Cancer Research UK Selects Lancope's StealthWatch System for Network Behavior Analysis.

StealthWatch Leverages NetFlow to Monitor and Protect Internal Network

ATLANTA -- Lancope, Inc., the provider of the StealthWatch[TM] System, the most widely used network behavior analysis (NBA) and response solution, today announced that Cancer Research UK, the world's leading independent organization dedicated to cancer research, has selected StealthWatch for powerful network performance monitoring and behavior-based anomaly detection. Deployed at key sites throughout the network, StealthWatch leverages NetFlow provided by the organization's Cisco network infrastructure to monitor the internal network as well as identify and resolve network incidents.

"StealthWatch can look at NetFlow and monitor the entire network - not just certain points as with intrusion detection/prevention systems," said Steve Switzer, network engineer for Cancer Research UK. "StealthWatch has already had an immediate and positive impact on our network."

"StealthWatch excels at providing a wealth of useful, actionable information about what is happening on the network," Switzer added. Cancer Research UK uses StealthWatch to quickly identify threats and affected hosts and servers, mitigate attacks and perform forensic analysis in order to maintain high network availability.

Cancer Research UK also selected StealthWatch for its "intuitive interface and ease of use." Praising StealthWatch's breadth of capabilities, Switzer said, "The easy configuration of the virtual security zones is very useful as another layer of network management and granularity."

"StealthWatch is an ideal solution for organizations like Cancer Research UK that must balance dynamic networks, open security policies and high availability," said Harland LaVigne, president and CEO of Lancope. "StealthWatch delivers end-to-end network visibility that allows organizations to quickly and cost-effectively identify, investigate and resolve network incidents."

About Cancer Research UK

Cancer Research UK is the world's largest independent organization devoted to cancer research, spending 213 million pounds Sterling annually on research and supporting the work of 3,000 scientists, doctors and nurses in more than 80 academic centres across the UK. The charity is the largest single force behind progress in cancer prevention, screening, diagnosis and treatment in the UK, and a European leader in the development of anti-cancer drugs. The organization's funding comes primarily through donations from the general public, community events and 650 shops around the UK. More than 30,000 volunteers help support Cancer Research UK's mission.

About Armana

Armana is a focused and experienced company in the IT Security Industry dedicated to providing security infrastructures driven by "policy" considerations rather than pure Vendor technology. The company believes its primary role is to understand customer requirements and model infrastructures best suited to needs given stated security criteria, policy directives and available budget. Armana's business objective is achieved through a relationship strategy where Armana manages excellent partnerships between its Vendors and Clients, and between Armana and its Vendors. By creating those trusted and successful interactions Armana assists Clients overcome their security challenges, better manage security risks and threats and provides excellent service for the lifetime of the security scheme deployed. It also allows Armana to meet another strategic objective that of providing first class, knowledgeable and committed solution delivery along with strong post sales support. Armana focused specialization is in the security countermeasure fields of network suspicious behavior detection and intrusion prevention, message filtering and email archiving, network access control [NAC] including USB security. ISO27001 is at the heart of its consultancy services.

About Lancope

Lancope is the provider of the StealthWatch[TM] System, the most widely used network behavior analysis (NBA) and response solution that unifies behavior-based anomaly detection and network optimization capabilities to protect critical information assets and ensure network performance by preventing costly downtime, repair and loss of reputation. StealthWatch streamlines security and network operations into one process, reduces time and resources, and eliminates the costs and complexity associated with non-integrated point products. Both OPSEC and Common Criteria-certified, StealthWatch was named Best of Show at Interop2006. Defending the networks of Global 2000 organizations, academic institutions and government entities, StealthWatch protects hundreds of enterprise customers worldwide, more than all direct competitors combined.

A contributing member of the Trusted Computing Group, Lancope also partners with fellow best-of-breed solution providers through its Technology Alliance Program, which includes Cisco Systems, Foundry Networks, IBM Tivoli, Check Point, TippingPoint, ArcSight and A10 Networks. Lancope is a privately held, venture-backed company headquartered in Atlanta, Georgia. For more information, call 770-225-6500 or visit www.lancope.com.

Lancope is a registered trademark and StealthWatch[TM] is a trademark of Lancope, Inc. All other registered or unregistered trademarks are the sole property of their respective owners.